
News|Articles|October 1, 2003
Abilify (Aripiprazole) Bristol-Myers Squibb/Otsuka
Maintenance therapy for schizophrenia
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Weakened brain connections linked to cognitive deficits in schizophrenia
3
Why the great pharma-MedTech divide is healthcare’s biggest miss
4
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
5



























